Article
FDA staff supports safety data for Pfizer's RSV vaccine to protect newborns
Rating:
0.0
Views:
80
Likes:
1
Library:
1
Safety data for Pfizer Inc's experimental respiratory syncytial virus (RSV) vaccine in pregnant women was "generally favorable", the U.S. Food and Drug Administration staff reviewers said on Tuesday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value